Skip to main content
. 2020 Nov 19;5(6):e001021. doi: 10.1136/esmoopen-2020-001021

Table 1.

Sample description

Variable N (%)*
Gender
 Men 7338 (74.3)
 Women 2538 (25.7)
Age
 Mean 64
 Median (pct 25 to 75) 65 (57 to 72)
Smoking status*
 Never smoker 1177 (11.9)
 Ex-smoker 4636 (46.9)
 Current smoker 3965 (40.1)
Histological type
 Adenocarcinoma 5138 (52.1)
 Squamous cell carcinoma 2394 (24.3)
 Small cell 1234 (12.5)
 Other histological types 1110 (11.2)
Stage at diagnosis
 I 824 (8.3)
 II 723 (7.3)
 III 2394 (24.2)
 IV 4600 (46.6)
 Small cell limited 449 (4.5)
 Small cell extended 783 (7.9)
 Other/unknown 103 (1.1)
Main symptoms
 Cough 3344 (33.9)
 Pain 2743 (23.8)
 Dyspnoea 2638 (26.7)
 Haemoptysis 1116 (11.3)
 Weight loss 2073 (21.0)
 Anorexia 601 (6.1)
 Asthenia 983 (10.0)
 Superior vena cava syndrome 53 (0.5)
 Aphonia or voice alterations 313 (3.2)
Number of symptoms at diagnosis
 0 3112 (31.5)
 1 2710 (27.4)
 2 2077 (21.0)
 3 1231 (12.5)
 four or more 502 (7.6)

*1% of participants had unknown smoking status.